retatrutide glp-1 gip glucagon triple agonist mechanism GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation Retatrutide: How the Triple Agonist
Description
Both analyses were performed using the same methods as the primary analysis (ESM Tables 68)
the project category is Natura Science Fund, and the project nos
Acute Kidney Injury Due to Volume Depletion Inform patients of the potential risk of acute kidney injury due to dehydration associated with gastrointestinal adverse reactions
GLP-1 RAs are used for managing blood glucose levels in people with type 2 diabetes mellitus and have also been licensed for use in weight loss treatment
It is a systemic inflammatory condition
